LENVATINIB for Bladder cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 7 adverse event reports in the FDA FAERS database where LENVATINIB was used for Bladder cancer.
Most Reported Side Effects for LENVATINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 4,262 | 12.6% | 321 | 2,714 |
| Hypertension | 4,152 | 12.3% | 405 | 2,522 |
| Fatigue | 3,603 | 10.7% | 208 | 2,023 |
| Decreased appetite | 3,257 | 9.7% | 363 | 2,209 |
| Malignant neoplasm progression | 2,929 | 8.7% | 1,549 | 1,298 |
| Nausea | 2,492 | 7.4% | 160 | 1,637 |
| Blood pressure increased | 2,228 | 6.6% | 104 | 1,411 |
| Vomiting | 1,962 | 5.8% | 122 | 1,458 |
| Asthenia | 1,643 | 4.9% | 122 | 1,180 |
| Malaise | 1,602 | 4.7% | 241 | 989 |
| Weight decreased | 1,529 | 4.5% | 106 | 901 |
| Dehydration | 1,526 | 4.5% | 97 | 1,375 |
| Pyrexia | 1,438 | 4.3% | 134 | 1,149 |
| Hypothyroidism | 1,375 | 4.1% | 165 | 698 |
| Headache | 1,268 | 3.8% | 50 | 810 |
Other Indications for LENVATINIB
Endometrial cancer (6,770)
Hepatocellular carcinoma (5,384)
Renal cell carcinoma (3,849)
Renal cancer (2,862)
Thyroid cancer (2,668)
Uterine cancer (2,233)
Hepatic cancer (1,017)
Clear cell renal cell carcinoma (935)
Product used for unknown indication (916)
Papillary thyroid cancer (501)
Other Drugs Used for Bladder cancer
BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN (1,279)
PEMBROLIZUMAB (869)
GEMCITABINE (841)
CISPLATIN (780)
ENFORTUMAB VEDOTIN-EJFV (530)
NIVOLUMAB (512)
ATEZOLIZUMAB (487)
CARBOPLATIN (332)
BACILLUS CALMETTE-GUERIN ANTIGEN, UNSPECIFIED SUBSTRAIN (326)
GEMCITABINE\GEMCITABINE (240)